ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
Author
dc.contributor.author
Tapia, Teresa
Author
dc.contributor.author
Sánchez, Alejandro
es_CL
Author
dc.contributor.author
Vallejos, Maricarmen
es_CL
Author
dc.contributor.author
Álvarez, Carolina
es_CL
Author
dc.contributor.author
Moraga Vergara, Mauricio
es_CL
Author
dc.contributor.author
Smalley, Susan
es_CL
Author
dc.contributor.author
Camus, Mauricio
es_CL
Author
dc.contributor.author
Álvarez, Manuel
es_CL
Author
dc.contributor.author
Carvallo, Pilar
es_CL
Admission date
dc.date.accessioned
2014-01-08T18:58:04Z
Available date
dc.date.available
2014-01-08T18:58:04Z
Publication date
dc.date.issued
2008
Cita de ítem
dc.identifier.citation
Breast Cancer Res Treat (2008) 107:281–288
en_US
Identifier
dc.identifier.other
DOI 10.1007/s10549-007-9544-5
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129113
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Besides BRCA1 and BRCA2, two genes
accounting for a small proportion of breast cancer cases,
ATM has been widely proposed as a low-penetrance susceptibility
gene. Several nucleotide changes have been
proposed to be associated with breast cancer, still
remaining a high controversy in this sense. We screened
the ATM gene in 94 breast cancer patients selected from 78
high-risk families, not presenting a mutation in BRCA1 or
BRCA2. We found three novel allelic variants:
IVS64 + 51delT and p.L752L, not showing association
with hereditary breast cancer, and p.L694L found in one
family in two breast cancer patients. Two amino acid
substitutions p.S707P and p.F858L, previously reported to
be associated with breast cancer, were present in our study
in cases and controls, lacking of association with breast
cancer. A positive association of c.5557G>A (p.D1853N)
was found (OR 2.52, P = 0.008), when analyzed alone and
in combination with an intronic variant IVS24-9delT (OR
3.97; P = 0.0003). We postulate that our discrepancies
with other reports related to the associated ATM alleles to
hereditary breast cancer, as well as discrepancies in the
literature between other groups, could be explained by the
diversity in the ethnic origins of families gathered in a sole
study, and the selection of the control group. In relation to
this issue, and based on genetic markers, we found that the
Chilean group of breast cancer families in this study has a
stronger European genetic component than our control
sample selected randomly from the Chilean population.